Willingness to wait before getting COVID-19 vaccine once available in Italy 2020

Published by
Juliette Gagliardi,
Jun 19, 2022
According to the results of a survey regarding the COVID-19 vaccine conducted among in Italy in October 2020, the largest share (38 percent) or respondents stated that they would take the COVID-19 vaccine within the first months of its release. On the other hand, 11 percent of the respondents were more hesitant. This group of people declared that they would prefer to wait more than one year after the vaccine is release.

How many months would you wait before getting the COVID-19 vaccine once it is available to the public?

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

In cooperation with
Release date

October 2020

Region

Italy

Survey time period

October 2020

Number of respondents

871 respondents

Age group

18 years and older

Method of interview

Online panel

Supplementary notes

This question was phrased by the source as follows: "Quanti mesi aspetteresti prima di sottoporti al vaccino anti Covid-19, una volta che questo sarà considerato sicuro, approvato e disponibile al pubblico?"

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Coronavirus: the pharma and medtech response "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

COVID-19 vaccination rate in GermanyCoronavirus (COVID-19) in FranceVaccinations in EuropeCoronavirus (COVID-19) in SpainVaccinations in Germany
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.